Expression of bone morphogenetic protein receptors Type-IA, -IB, and -II correlates with tumor grade in human prostate cancer tissues

Citation
Iy. Kim et al., Expression of bone morphogenetic protein receptors Type-IA, -IB, and -II correlates with tumor grade in human prostate cancer tissues, CANCER RES, 60(11), 2000, pp. 2840-2844
Citations number
22
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
60
Issue
11
Year of publication
2000
Pages
2840 - 2844
Database
ISI
SICI code
0008-5472(20000601)60:11<2840:EOBMPR>2.0.ZU;2-R
Abstract
Bone morphogenetic proteins (BMPs) are potential regulators of prostate can cer cell growth and metastasis that signal through an interaction with BMP membrane receptors (BMPRs) type I and type II. In the present study, Wester n blot and immunohistochemical analysis of BMPRs were carried out in benign and malignant human prostate tissues to explain the loss of BMP response i n human prostate cancer cells. The results demonstrated that the benign pro state specimens expressed high levels of all three BMPRs. In normal prostat e, BMPRs were localized predominantly to epithelial cells. Among prostate c ancer specimens, well-differentiated dancers were positive for the expressi on of BMPR-II, BMPR-IA, and BMPR-IB, for the most part. In contrast, only 1 of 10 poorly differentiated prostate cancer cases was positive for each of the three BMPRs (P < 0.005 for all three receptors), Taken together, these results indicate that human prostate cancer cells frequently exhibit loss of expression of BMPRs and suggest that loss of BMPRs may play an important role during the progression of prostate cancer.